References
- Rice DP, Miller LS. The economic burden of affective disorders. Presented before International Workshop on Costs and Assessment in Psychiatry: The Costs of Affective Disorders. Venice, Italy: 1992 Oct
- Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 1989; 262(7): 914–9
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3d ed, rev. Washington, DC: American Psychiatric Assoc, 1987
- Quitkin FM, McGrath P, Liebowitz MR, et al. Monoamine oxidase inhibitors in bipolar endogenous depressives. J Clin Psychopharma- col 1981; 1(2): 70–4
- Soviler RD. The clinical characteristics and treatment of atypical depression. J Clin Psychiatry 1981; 42(7): 285–9
- Davidson JR, Miller RD, Turnbull CD, et al. Atypical depression. Arch Gen Psychiatry 1982; 39(5): 527–34
- Angst J. The course of major depression, atypical bipolar disorder, and bipolar disorder. In: Hippius H, Klerman GL, Matussek N, et al, eds. New results in depression research. New York: Springer-Verlag, 1986: 26–35
- Maj M, Veltro F, Pirozzi R, et al. Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study. Am J Psychiatry 1992; 149(6): 795–800
- Keller MB, Merman GL, Lavori PW, et al. Long-term outcome of episodes of major depression: clinical and public health significance. JAMA 1984; 252(6): 788–92
- Reich T, Clayton PJ, Winokur G. Family history studies: V. The genetics of mania. Am J Psychiatry 1969; 125(10): 1358–69
- Baron M, Risch N, Hamburger R, et al. Genetic linkage between X-chromosome markers and bipolar affective illness. Nature 1987; 326(6110): 289–92
- Mendlewicz J, Simon P, Sevy S, et al. Polymorphic DNA marker on X chromosome and manic depression. Lancet 1987; 1(8544): 1230–2
- Holden C. Depression: the news isn't depressing. Science 1991; 254(5037): 1450–2
- Williamson PS, Yates WR. The initial presentation of depression in family practice and psychiatric outpatients. Gen Hosp Psychiatry 1989; 11 (3): 188–93; discussion 216–21
- Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264(19): 2511–8
- Glassman AH, Bigger JT Jr. Cardiovascular effects of therapeutic doses of tricyclic antidepressants: a review. Arch Gen Psychiatry 1981; 38(7): 815–20
- Ziegler VE, Clayton PJ, Taylor JR, et al. Nortriptyline plasma levels and therapeutic response. Clin Pharmacol Ther 1976; 20(4): 458–63
- Nelson JC, Jallow P, Quinlan DM, et al. Desipramine plasma concentration and antidepressant response. Arch Gen Psychiatry 1982; 39(12): 1419–22
- Wernicke JF, Dunlop SR, Domseif BE, et al. Fixed-dose fluoxetine therapy for depression. Psychopharmacol Bull 1987; 23(1): 164–8
- Beasley CM Jr, Dornseif BE, Bosom-worth JC, et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ 1991; 303 (6804): 685–92 [erratum, BMJ 1991; 303(6808): 968]
- Mann JJ, Kapur S. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy. Arch Gen Psychiatry 1991; 48(11): 1027–33
- Guze SB, Robins E. Suicide and primary affective disorders. Br J Psychiatry 1970; 117(539): 437–8